Motley Fool Asset Management LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Motley Fool Asset Management LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2020$2,493,000
+46.3%
877,667
+41.7%
0.22%
+29.8%
Q2 2020$1,704,000
+27.5%
619,590
+9.5%
0.17%
-1.2%
Q1 2020$1,336,000
-50.2%
565,932
-0.9%
0.17%
-39.9%
Q4 2019$2,683,000
+35.8%
570,810
-3.3%
0.29%
+25.2%
Q3 2019$1,975,000
+205.3%
590,322
+200.0%
0.23%
+219.4%
Q2 2019$647,000196,8000.07%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders